-
Piper Jaffray Maintains Overweight on Hologic (HOLX)
Friday, March 25, 2011 - 8:54am | 122Piper Jaffray is out with its report today on Hologic (NASDAQ: HOLX), reiterating Overweight. In a note to clients, Piper Jaffray writes, "With ~200 Tomo-ready systems seeded in the U.S., we believe there is ample room for upside to our forward expectations. Although management remains...
-
Piper Jaffray Reiterates UW Rating, $22 PT On GB
Friday, March 25, 2011 - 7:53am | 97Piper Jaffray is reiterating its Underweight rating and $22 PT on shares of Greatbatch, Inc. (NYSE: GB). “We think Greatbatch is on the right strategy to increase its top line growth prospects and profitability profile,” Piper Jaffray writes. “But with the stock currently trading at 14x our C12...
-
Piper Jaffray Maintains OW Rating On BAX
Friday, March 25, 2011 - 7:47am | 114Piper Jaffray is maintaining its OW rating on shares of Baxter International Inc. (NYSE: BAX). “Adjusted ‘apples-to-apples' US IVIG distributions improved again in February, up 10% vs. the prior year,” Piper Jaffray writes. “Growth among major players continues to be driven by share gains...
-
Active Screen - CANSLIM: Top 8 for March 24th
Friday, March 25, 2011 - 6:52am | 1161Another week with no change. The Top-8 as ranked by Market Cap remain Apple (AAPL), Vale S.A. (VALE), Barrick Gold (ABX), Free McMoran (FCX), Baidu (BIDU), Research in Motion (RIMM), Cognizant Technlogy (CTSH), and Intuitive Surgical (ISRG). The Screener setup was as follows: The past week has...
-
Options Brief: Covidien Public Limited Company (COV)
Thursday, March 24, 2011 - 10:37am | 92Shares of Covidien Public Limited Company (NYSE: COV) are higher on the session by 0.20%, trading at $51.69. Overall call volume is now running at 2.25x the daily average, with 32% of all calls traded being purchases on the offer. 3,222 contracts have traded on the session so far. Covidien...
-
Boston Scientific Receives FDA Approval of New Clik Anchor for Precision Plus Spinal Cord Stimulator System
Thursday, March 24, 2011 - 8:37am | 123Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Clik™ Anchor for its Precision Plus™ Spinal Cord Stimulator (SCS) System, the world's first rechargeable SCS device for chronic pain management. The Clik Anchor...
-
Boston Scientific Receives FDA Approval of New Clik (BSX)
Thursday, March 24, 2011 - 8:34am | 390Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Clik™ Anchor for its Precision Plus™ Spinal Cord Stimulator (SCS) System, the world's first rechargeable SCS device for chronic pain management. The Clik Anchor...
-
Benzinga's Top Downgrades (HOLX, DGW, TAM, BAC)
Thursday, March 24, 2011 - 8:14am | 139Hologic Inc (NASDAQ: HOLX) was downgraded by Gleacher from "neutral" to "sell." HOLX's shares closed at $21.78 yesterday. Hologic's PEG ratio is 2.03. Rodman & Renshaw downgraded Duoyuan Global Water Inc (NYSE: DGW) from “outperform” to “market perform.” DGW's stock closed at $7.22 yesterday....
-
Morgan Stanley Anticipates Rise In EW Share Price
Thursday, March 24, 2011 - 8:03am | 136“We believe the share price will rise in absolute terms over the next 60 days,” Morgan Stanley wrote in a report this morning regarding Edwards Lifesciences Corp. (NYSE: EW). :Edwards will present key data from the PARTNER Cohort A trial at the American College of Cardiology meeting in New Orleans...
-
Rockwell Medical Starts Pivotal Phase III Clinical Study for Treatment of Iron Deficiency in Dialysis Patients
Thursday, March 24, 2011 - 7:41am | 117Rockwell Medical (Nasdaq: RMTI) announced today that it has commenced enrollment in its pivotal Phase III CRUISE-1 clinical study, designed to treat iron deficiency anemia in hemodialysis dependent-chronic kidney disease patients receiving erythropoietin. Rockwell is conducting two pivotal Phase...
-
Canaccord Ups VIVO To Buy
Thursday, March 24, 2011 - 6:49am | 38Analysts at Canaccord upgrade Meridian Bioscience Inc (NASDAQ: VIVO) from “hold” to “buy.” VIVO shares closed at $21.37 yesterday. More Analyst Ratings here
-
Mad Money Lightning Round OT: Cramer Is Not A Buyer Of EW (NLY, CIM, EW, BKI)
Wednesday, March 23, 2011 - 8:40pm | 208On CNBC's Mad Money Lightning Round OT, Jim Cramer said that he prefers Annaly Capital Management, Inc. (NYSE: NLY) over Chimera Investment Corporation (NYSE: CIM). He explained that these stocks have about equal dividend yield, but when Treasury starts selling its portfolio that is going to be...
-
Biodefense Stocks/ Homeland Defense Stock Alert; Dynasil Corporation trading at $6.26, up 2.50 (66.49%)
Wednesday, March 23, 2011 - 2:17pm | 724Point Roberts, WA - March 23, 2011 - Investorideas.com, a leader in investor sector research including Homeland Defense and Biodefense Stocks issues a trading alert on the sector as Dynasil Corporation of America(NasdaqGM: DYSL) becomes the top gainer on the NASDAQ on patent news for its radiation...
-
Homeland Defense Stocks; Dynasil Corporation (NASDAQ GM:DYSL) Announces Patent Approvals For Advanced Radiation Detection and Increased Detector Production Capacity
Wednesday, March 23, 2011 - 9:00am | 24WATERTOWN, Mass. - March 23, 2011 (Investorideas.com newswire) - Dynasil Corporation (NASDAQ GM:DYSL), announced today that its research division, Radiation Monitoring Devices, Inc. (RMD),
-
Homeland Defense Stocks; Dynasil Corporation (NASDAQ GM:DYSL) Announces Patent Approvals For Advanced Radiation Detection and Increased Detector Production Capacity
Wednesday, March 23, 2011 - 9:00am | 24WATERTOWN, Mass. - March 23, 2011 (Investorideas.com newswire) - Dynasil Corporation (NASDAQ GM:DYSL), announced today that its research division, Radiation Monitoring Devices, Inc. (RMD),